Shlomo Flechter
Ramat Gan, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Cladribine treatment for highly active multiple sclerosis: Real-world clinical outcomes for years 3 and 4.
Journal: Journal of neuroimmunology
Published: June 18, 2022
Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod.
Journal: Journal of neurology
Published: December 15, 2021
COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose.
Journal: Journal of the neurological sciences
Published: November 08, 2021
SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: October 01, 2021
Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study.
Journal: Journal of neuroimmunology
Published: August 31, 2021
Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies.
Journal: Therapeutic advances in neurological disorders
Published: June 09, 2021
COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: April 15, 2021
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies.
Journal: Therapeutic advances in neurological disorders
Published: March 17, 2021
Immunoglobulin free light chains in saliva: a potential marker for disease activity in multiple sclerosis.
Journal: Clinical and experimental immunology
Published: November 20, 2017
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.
Journal: Brain : a journal of neurology
Published: February 07, 2017
Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: May 12, 2016
The effect of additional ankle and midfoot mobilizations on plantar fasciitis: a randomized controlled trial.
Journal: The Journal of orthopaedic and sports physical therapy
Published: March 06, 2015
Last Updated: 09/26/2026